Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Obviously I agree with you
So you have China with possibly the reduce it label, Europe, 90% of US market and trials for colon cancer, Alzheimer’s etc etc etc and ultimate payout for some of you that you would be happy with is $15???
If Alzheimer’s trial is positive that would be like the holy grail. A friend of mine who is high up in a BP company said that would be the ultimate result
Again hear me out I am not saying let’s sit around 3 to 5 more years hoping for these type results but don’t sell the company on the cheap. Do something that if these type of trials are positive that we are rewarded.
Cvr’s probably are the answer
I have no problem if company is sold but not on the cheap. If we could get as zmanindc said somewhere in the $20’s for the company with cvr’s for future indications and US I would be completely fine with that
I would not be fine with $15 and that is it.
Where would stock price be in we didn’t get f’d by Judge du???
Stock price can turn on a dime and you know that. All I am saying is I don’t want them to sell on the cheap and IMO mid teens is the cheap
What do you consider young?
Ok I agree with that but cvr’s for those indications and for us??? That would make sense to me
Correct because the trial results are not known yet. If they are positive what will happen to the share price???
IMO company worth much more then mid teens. I don’t care about present stock price I care about future opportunities. Been in this too long to give it up on the cheap
If success of these trials could push the stock to $50 plus minimum and I have read more then once that there is a relatively decent chance on success with the Alzheimer’s study ( don’t remember anyone chiming in on success with colon cancer) why on earth would be want to sell for low teens.
Doesn’t make sense to me especially when we have so many other catalysts that could get us much higher then mid teens as has already been stated
If the reason is you are sick of waiting and have had enough of the stock then personally you should move on IMO. I have been here since 2011 and yes I would love it to happen now but not in the cards and 2 more years for me is okay to get the best payout
If success of these trials could push the stock to $50 plus minimum and I have read more then once that there is a relatively decent chance on success with the Alzheimer’s study ( don’t remember anyone chiming in on success with colon cancer) why on earth would be want to sell for low teens.
Doesn’t make sense to me especially when we have so many other catalysts that could get us much higher then mid teens as has already been stated
If the reason is you are sick of waiting and have had enough of the stock then personally you should move on IMO. I have been here since 2011 and yes I would love it to happen now but not in the cards and 2 more years for me is okay to get the best payout
Alot of the price targets are too low IMO. The US market is not lost. I agree with pharmacydude that we will be over our high of $26 mid 2021...
China, Europe, Covid, 90 plus % of us market is worth more then $18 a share and I believe a BP will eventually pay for that. How high I don’t know but could be $30 plus if not higher.
Bio billionaire says possibly $20 billion that is $47 a share.
I know many will say your crazy but I don’t think so.
Thanks and agree IMO we will all be happy with the final outcome, maybe not $100 a share but high enough to be rewarded for all we have been through
Well my point is that there is a good chance the trials will be successful and that only increases the value of amarin in a buyout. Not questioning you that BP could market the drug better but I find it odd when people on this board keep on saying give me $10, or we will be lucky to get $15
Doesn’t make much sense to me as the value of amarin especially if these trials pan out is much higher IMO
I agree just seems like no one is factoring that in. From what I have been reading seems like the trials have a very good chance of being successful
With Covid spiking up again why wouldn’t a successful trial showing vascepa helping Covid Patients not be a huge increase to share price???
So when vascepa is proven to help with Covid patients you still feel the company is worth a max of $15 a share???
Not even factoring Europe and ROW for the reduce it indication and outside chance on US market
My thought is if generics know they can’t sell
More then 5% of total sales without infringement they probably
Don’t enter the market at all and may result in a settlement
Or if they do enter certainly are limited to total sales. Maybe hard to keep them at 5% but if they reach 10% or more that won’t be hard to prove they are infringing
No i don’t think so was asking bio what his thoughts are with this
Okay thanks but the only way she makes appeals decision is if the case is remanded back to her correct???
Bio what does it mean that she signed the order?
Ok thanks that sounds doable
Is it as easy as Hikma and dr reedy telling the judge to vacate her ruling if they agree to a settlement?
Is it as easy as Hikma and dr reedy telling the judge to vacate her ruling if they agree to a settlement?
How about presently this be an asymmetrical bet. We win the appeal and off to the races. We lose and we are basically where we are with Europe rights still.
Reminds me of the price per share after the adcom. If you took advantage of the stock being in the 1’s you are still up and up big
I didn’t buy at $4 a month ago just like I didn’t buy at .78 after the adcom but the stock price at $8 still looks awfully tempting
Not in Europe and rest of the world
Didn’t listen to the call. Was anything mentioned regarding DTC advertising or COVID19???
If you really think amarin isn’t looking into this then you shouldn’t be invested in the company. For sure they are. Unless it is proven the drug helps with the virus we won’t hear anything from the company other then what we have so far. Think Bhatt wouldn’t love to get this drug out there and how much better then showing it helps with the virus. Attacking Thero etc saying they aren’t doing anything is wrong IMO
RAF I second that amarin will win
BUT
This whole process is a complete joke to how our system works
I would love for 60 minutes to someday do a piece on this. Absolute joke.
This drug proven to reduce your chance of dying from a cv event by 25%, 25 friggin %. 1 and half years after the fact look at where we are at. Really sad
With everything being posted how can’t this be reversed? It seems obvious from everything being posted it should be. Am I missing something?
Couldn’t a settlement be done that wouldn’t allow the other generics to just step in for there piece and make them go thru what Hikma and dr reedy did? Have to believe that could be done
I think a settlement is how this will play out. Could almost hear it in Thero’s voice saying to generics the other day just settle and move on no reason you want this market now
Well that what constitutes an expedited review as compared to a regular review???
Am I correct in thinking that an expedited review means the case is very strong to be overturned?
Ok thanks guess the important thing is get best value for Europe and then focus solely on US
Can someone answer this please. Let’s say we sell and
Close on Europe for $15 a share does that get added to the share price? So if that happened today we would be $20.04 ($15 + $5.04)
Just curious how that works thanks
I know I already agreed with you on this but I have been thinking this all day just never posted it. Sell Europe lock in whatever we get and go after getting US back. Company has fought way too hard and long to give it away. I am on record that we find a way either by winning appeal or settlement.
I like that idea lock the money in for Europe and fight there asses off for US
How much is reasonable for a cvr in total as there may be different milestones such as x amount if appeal is won and x if so much achieved in sales etc
If I am correct here Jesselivermore is saying vascepa will be lower price than the generic due to tier levels
That 1% could be the difference!!!!